RxDoctor Payments Data

Matthew Rien

Foot & Ankle Surgery · Harrisburg, PANPI 1396178984

Payments from drug & device makers

$2,442in general payments, 2019–2025

Across 116 payments — averaging $21.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$402
  • Smith+Nephew$399
  • Paratek Pharmaceuticals, Inc.$244
  • Treace Medical Concepts, Inc.$192
  • Kerecis Limited$124
  • Osiris Therapeutics Inc.$122
  • plus $959 from 24 others
$1,869in research payments, 2019–2025

Across 5 payments — averaging $373.84 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Polarityte, Inc.$2K

What the payments were for

  • Speaking & faculty fees$191%
  • Food & beverage$2,42399%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,442 in reported general payments places this provider in the 50th percentile of 575 foot & ankle surgery providers in Pennsylvania.

See all foot & ankle surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$134,753
Medicare patients
415
Services billed
2,051

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ammonium Lactate46$1,123
Ketoconazole11$378
Doxycycline Hyclate52$281
Cephalexin12$129
Methylprednisolone16$89

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Harrisburg

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →